Clinical Trial

STEAM-MAP 1 Study - Steam Therapy With MRI and AI-assisted Planning

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The STEAM-MAP 1 Study is a single-arm, prospective feasibility trial evaluating the integration of MRI-transrectal ultrasound (TRUS) fusion guidance into Rezūm water vapor thermal therapy for men with symptomatic benign prostatic hyperplasia (BPH).
Trial Details
NCT Number NCT07663344
Lead Sponsor Chinese University of Hong Kong
Conditions Benign Prostatic Hyperplasia (BPH)
Enrollment 15 participants
Start Date 2026-06-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-23